-

Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces

A revolutionary advancement in X-ray photoelectron spectroscopy (XPS) depth profiling

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the world.

Innovation to Improve Society
The Hypulse Surface Analysis System will enable the development of surfaces across industries to improve society — from advancing energy storage, to evolving medical implants, to enhancing fire protection. This new generation of XPS depth-profiling will enable researchers to extract more insights from surface samples and create better materials. In the case of medical implants, for example, these insights can pave the way for research that will help upgrade coatings for better biocompatibility, longevity and infection prevention.

Femtosecond Laser Technology: Insights Beyond the Surface
What sets the Thermo Scientific Hypulse Surface Analysis System apart is that it is equipped with a novel material-removal method: femtosecond laser technology. This allows researchers to preserve sample accuracy, accelerate data collection and characterize more materials at greater depths.

"The femtosecond laser has many advantages,” says Professor Mark Baker, surface science and engineering at the University of Surrey in the United Kingdom. “First, it enables us to avoid chemical damage because it changes the material-removal mechanism from a ballistic process to an electrostatic process, allowing us to record the original, true composition in the profile. Second, we can record depth much quicker. The third advantage is that we now have the ability to vary energy in the laser, enabling us to profile to greater depths.”

“With Hypulse, we’ve retained our industry-leading surface technology while pushing ourselves to meet customer needs of today and tomorrow,” says David Wall, vice president and general manager of materials science for Thermo Fisher Scientific. “We’ve combined our proven MAGCIS™ ion source with the femtosecond laser, so that our customers can examine samples when ion beam technology is not suitable.”

To learn more about the Thermo Scientific Hypulse Surface Analysis System, please visit our website or visit booth 601 at the AVS International Symposium and Exhibition in Charlotte, North Carolina, September 23-25.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies. Accelerating Drug Discovery with Cryo-EM The...

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1. Invasive fungal infections are an increasing challenge for healthcare systems w...

Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner

WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType™ Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection. For transplant recipients, finding the right tacrolimus dose as early as possible can be life-changing. If the dose is too low, the body may...
Back to Newsroom